Skip to main content
. 2016 Feb 9;7(14):17711–17725. doi: 10.18632/oncotarget.7293

Table 2. Mutated pathways and functions in each group of patients.

Good prognosis
FUNCTION score good score poor dif.score p-val
APOPTOSIS (KEGG) 0.903 0.432 −0.472 0.001
SMALL CELL LUNG CANCER (KEGG) 0.828 0.452 −0.376 0.012
DILATED CARDIOMYOPATHY (KEGG) 0.837 0.540 −0.297 0.039
VEGF SIGNALING PATHWAY (KEGG) 0.817 0.538 −0.279 0.037
CELL CYCLE (KEGG) 0.621 0.365 −0.256 0.020
LIPID KINASE ACTIVITY (GO) 1.863 0.487 −1.376 0.002
INOSITOL OR PHOSPHATIDYLINOSITOL KINASE ACTIVITY (GO) 1.242 0.325 −0.917 0.002
Poor prognosis
FUNCTION score good score poor dif.score p-val
NUCLEOTIDE EXCISION REPAIR (KEGG) 0.113 0.398 0.285 0.050
TIGHT JUNCTION (KEGG) 0.389 0.654 0.265 0.019
DNA POLYMERASE ACTIVITY (GO) 0.000 0.812 0.812 0.008
DNA DIRECTED DNA POLYMERASE ACTIVITY (GO) 0.000 0.626 0.626 0.008